Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA3 | P07451 | 1/20 | 0.52 |
| ▸ | CA6 | P23280 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
| ▸ | CYP19A1 | P11511 | 7/20 | 0.47 |
| ▸ | MMP3 | P08254 | 1/20 | 0.46 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | GSK3B | P49841 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11603519 | 0.91 | TSHR (0.54) | CA2CA12CA3CA6CA9 | |
| SCHEMBL2296391 | 0.86 | CYP2A6 (0.44) | CA2CA12CA3CA6CA9 | |
| SCHEMBL691258 | 0.84 | CA2 (0.52) | CA2CA12CA3CA6CA9 | |
| SCHEMBL26162676 | 0.84 | CA2 (0.52) | CA2CA12CA3CA6CA9 | |
| SCHEMBL14965641 | 0.81 | MAPT (0.43) | CA2CA12CA3CA6CA9 | |
| SCHEMBL4562130 | 0.81 | MMP3 (0.50) | CA2CA12CA3CA6CA9 | |
| SCHEMBL7306437 | 0.81 | LOXL2 (0.45) | CA2CA12CA3CA6CA9 | |
| SCHEMBL4728041 | 0.80 | PGR (0.49) | CA2CA12CA3CA6CA9 | |
| SCHEMBL342986 | 0.80 | PGR (0.49) | CA2CA12CA3CA6CA9 | |
| SCHEMBL320277 | 0.80 | PGR (0.49) | CA2CA12CA3CA6CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2067761-B1 | METHOD OF PRODUCING DIOL, POLYDIOL, SECONDARY ALCOHOL OR DIKETONE COMPOUND | JAPAN SCIENCE & TECH AGENCY (JP) | 2015-07-08 | — | — | EP | disclosed |
| US-7696386-B2 | Method of producing diol, polydiol, secondary alcohol or diketone compound | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2010-04-13 | — | — | US | disclosed |
| US-20090240085-A1 | METHOD OF PRODUCING DIOL, POLYDIOL, SECONDARY ALCOHOL OR DIKETONE COMPOUND | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2009-09-24 | — | — | US | disclosed |
| EP-2067761-A1 | METHOD OF PRODUCING DIOL, POLYDIOL, SECONDARY ALCOHOL OR DIKETONE COMPOUND | Japan Science and Technology Agency (JP) | 2009-06-10 | — | — | EP | disclosed |
| US-4087463-A | COBALT CARBONYL CATALYST | MONSANTO COMPANY (US) | 1978-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090240085-A1 | METHOD OF PRODUCING DIOL, POLYDIOL, SECONDARY ALCOHOL OR DIKETONE COMPOUND | HSD17B7, ADH1C, DHCR7 | CA2 863/4885CA12 154/4885CA3 161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.